| | SLO | ENG | Piškotki in zasebnost

Večja pisava | Manjša pisava

Izpis gradiva Pomoč

Naslov:Overview of probiotic strains of Weizmannia coagulans, previously known as Bacillus coagulans, as food supplements and their use in human health
Avtorji:ID Fijan, Sabina (Avtor)
ID Fijan, Tamara (Avtor)
ID Connil, Nathalie (Avtor)
Datoteke:.pdf 2023-applmicrobiol-coagulans.pdf (382,46 KB)
MD5: C45F0CC6F47CAD5834FE86E3A4F0A93B
 
Jezik:Angleški jezik
Vrsta gradiva:Znanstveno delo
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:FZV - Fakulteta za zdravstvene vede
Opis:Weizmannia coagulans, previously known as Bacillus coagulans and before that as Lactobacillus sporogenes, is a spore-forming, lactic acid-producing, Gram-positive, bacillus-shaped bacterial species with several known probiotic strains, including GBI-30, 6086 Unique IS-2, MTCC 5856, LBSC (DSM 17654), TBC169, SNZ 1969, BC30, and T11. This review focusses on the health benefit of these strains. A total of 53 clinical trials were found to use various strains of Weizmannia coagulans. However, 19 of these clinical trials did not provide strain information. Clinical evidence has shown that supplementation with strains of Weizmannia coagulans resulted in statistically significant health effects in the probiotic groups compared to the placebo. Several health benefits of the Weizmannia coagulans strains were found including relieving symptoms of irritable bowel syndrome, constipation, diarrhoea, and other gastrointestinal symptoms, function recovery treatment of non-fatty liver disease, after surgery or in patients with rheumatoid arthritis, quality of life and glucose- and lipid-related biomarkers related to overweight or obese participants or diabetic patients, absorption of protein or muscle integrity and improvement of peri- and post-menopausal symptoms. The main mechanism of action is the modulation of the intestinal microbiota and host immunity. However, in terms of several clinical studies involving small patient populations, others did not provide strain information. Larger, well-designed clinical studies are warranted to support the health benefits of Weizmannia coagulans strains.
Ključne besede:spore-forming bacteria, probiotics, Bacillus coagulans, Weizmannia coagulans
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Poslano v recenzijo:01.08.2023
Datum sprejetja članka:14.08.2023
Datum objave:21.08.2023
Založnik:MDPI
Leto izida:2023
Št. strani:str. 935-947
Številčenje:Letn. 3, št. 3
PID:20.500.12556/DKUM-95796 Novo okno
UDK:613.292:579.864
COBISS.SI-ID:161912323 Novo okno
DOI:10.3390/applmicrobiol3030064 Novo okno
ISSN pri članku:2673-8007
Datum objave v DKUM:23.10.2025
Število ogledov:235
Število prenosov:3
Metapodatki:XML DC-XML DC-RDF
Področja:Ostalo
:
Kopiraj citat
  
Skupna ocena:(0 glasov)
Vaša ocena:Ocenjevanje je dovoljeno samo prijavljenim uporabnikom.
Objavi na:Bookmark and Share



Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:21.08.2023

Komentarji

Dodaj komentar

Za komentiranje se morate prijaviti.

Komentarji (0)
0 - 0 / 0
 
Ni komentarjev!

Nazaj
Logotipi partnerjev Univerza v Mariboru Univerza v Ljubljani Univerza na Primorskem Univerza v Novi Gorici